Status:
RECRUITING
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
Breast Cancer Research Foundation
Susan G. Komen Breast Cancer Foundation
Conditions:
Breast Cancer
Breast Neoplasms
Eligibility:
FEMALE
20-74 years
Phase:
NA
Brief Summary
Phase 4 of the Carolina Breast Cancer Study (CBCS4) builds on prior phases that examined molecular and epidemiologic differences in breast cancer types and outcomes. Previous findings showed that cert...
Detailed Description
Study Population will be 3300 participants with invasive breast cancer among women aged 20-74 in 59 North Carolina counties between will be enrolled. Approximately 1,500 Black women (750 aged \<50 and...
Eligibility Criteria
Inclusion
- women with invasive breast cancer
- live in 59 counties in North Carolina
Exclusion
- women with ductal carcinoma in situ (DCIS)
- live outside of 59 counties of North Carolina
Key Trial Info
Start Date :
November 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2044
Estimated Enrollment :
3300 Patients enrolled
Trial Details
Trial ID
NCT07214610
Start Date
November 28 2023
End Date
December 31 2044
Last Update
October 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599